US Stock MarketDetailed Quotes

MSTR MicroStrategy

Watchlist
  • 393.000
  • -2.010-0.51%
Trading Dec 9 10:00 ET
92.05BMarket Cap-159886P/E (TTM)

MicroStrategy Key Stats

MicroStrategy Q3 2024 Earnings Date

Overview | MSTR reported earnings of $1.56 per share on revenue of $116.1 million for the quarter, it held approximately 252,220 bitcoins, acquired for $9.9 billion at an average purchase price of $39,266 per bitcoin

Currency:USDOct 30, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
121.45M
116.07M
-5.38M
Miss Est.
-6.19%
-10.34%
-4.43%
EPS
-0.12
-1.72
-1.60
Miss Est.
+87.82%
-70.30%
-1299.51%
Strong Buy

Nov 30, 2024

MicroStrategy Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 115.223M--
--2024/Q4-- / 123.522M--
Oct 30, 20242024/Q3116.071M / 121.454M--
Aug 1, 20242024/Q2111.442M / 121.986M--
Apr 29, 20242024/Q1115.246M / 121.380M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 115.223M--
--2024/Q4-- / 123.522M--
Oct 30, 20242024/Q3116.071M / 121.454M
Aug 1, 20242024/Q2111.442M / 121.986M--
Apr 29, 20242024/Q1115.246M / 121.380M--

Unlock Free Earnings Estimates

MicroStrategy Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data